Mitodicure (@mitodicure) 's Twitter Profile
Mitodicure

@mitodicure

Start-up with the mission to cure ME/CFS and Fibromyalgia.

Follow us on LinkedIn: linkedin.com/company/mitodi…

ID: 1564903608658927616

linkhttps://mitodicure.com calendar_today31-08-2022 09:11:36

4 Tweet

1,1K Takipçi

60 Takip Edilen

Gate.io (@gate_io) 's Twitter Profile Photo
Gate.io
@gate_io

5 hours ago

🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358
Mitodicure (@mitodicure) 's Twitter Profile Photo
Mitodicure
@mitodicure

a year ago

#mitodicure launched its website: mitodicure.com We are the only #MECFS start-up company worldwide developing a novel targeted drug. Support innovative drug development aimed at healing ME/CFS, which is also the most severe form of #LongCovid. #BMBF #MECFSAwarenessDay

#mitodicure launched its website: mitodicure.com We are the only #MECFS start-up company worldwide developing a novel targeted drug. Support innovative drug development aimed at healing ME/CFS, which is also the most severe form of #LongCovid. #BMBF #MECFSAwarenessDay
Mitodicure (@mitodicure) 's Twitter Profile Photo
Mitodicure
@mitodicure

6 months ago

Review article by Carmen Scheibenbogen and Klaus Wirth, #mitodicure, shows that #MECFS is an Acquired Mitochondrial Myopathy. Mitodicure is a startup which develops a breakthrough drug to correct the key pathomechanisms maintaining ME/CFS. #LongCovid #BMBF onlinelibrary.wiley.com/doi/10.1002/jc…

Prof. Karl Lauterbach (@karl_lauterbach) 's Twitter Profile Photo
Prof. Karl Lauterbach
@karl_lauterbach

5 months ago

Die Arbeit im ⁦Bundesgesundheitsministerium⁩ geht weiter, Wahlkampf ist nicht alles. Heute Gespräch mit Prof. Wirth von Mitodicure zu MDC002. Der Wirkstoff ist einer der wichtigen Hoffnungsträger für die Behandlung von #LongCovid. Ich unterstütze bei der Beschaffung von Risikokapital.

Die Arbeit im ⁦<a href="/BMG_Bund/">Bundesgesundheitsministerium</a>⁩ geht weiter, Wahlkampf ist nicht alles. Heute Gespräch mit Prof. Wirth von Mitodicure zu MDC002. Der Wirkstoff ist einer der wichtigen Hoffnungsträger für die Behandlung von #LongCovid. Ich unterstütze bei der Beschaffung von Risikokapital.
Mitodicure (@mitodicure) 's Twitter Profile Photo
Mitodicure
@mitodicure

4 months ago

Huge thanks to Gez Medinger for this excellent work! youtube.com/watch?v=vU91aB…